Skip to main content
Top
Published in: Supportive Care in Cancer 2/2020

01-02-2020 | Central Venous Catheter | Review Article

Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis

Authors: Renata Cristina de Campos Pereira Silveira, Paula Elaine Diniz dos Reis, Elaine Barros Ferreira, Fernanda Titareli Merizio Martins Braga, Cristina Maria Galvão, Alexander Michael Clark

Published in: Supportive Care in Cancer | Issue 2/2020

Login to get access

Abstract

Purpose

To identify the most effective dressing for covering long-term central venous catheter exit site to prevent catheter-related infections and skin irritation in patients undergoing hematopoietic stem cell transplantation.

Methods

Systematic Review. The search was performed in the following electronic databases: CINAHL, Cochrane Library CENTRAL, EMBASE, LILACS, PubMed, Scopus, and Web of Science. Google Scholar was used for the gray literature search.

Results

Seven studies were included which tested different arrangements of dressings: sterilized gauze and adhesive tape with a transparent polyurethane film (n = 2), transparent polyurethane film with a different replacement interval frequency (n = 2), transparent polyurethane film with and without chlorhexidine released continuously by the dressing at the site of intravascular catheter insertion (n = 2), and dressings vs. no dressings (n = 1). The meta-analysis for catheter-related infection prevention showed no difference between type of dressing (RR 1.76, [95% CI 0.82; 3.75], I2 0%) and for the replacement frequency at different intervals (RR 1.04, [95% CI 0.67; 1.61], I2 0%). The meta-analysis for skin irritation evaluated the transparent polyurethane film replacement frequency and indicated that a longer dressing replacement interval (10 to 15 days) reduces the risk of developing this outcome (RR 0.71, 0.52; 0.96, 95% CI, I2 24%).

Conclusions

Regarding the type of the dressing, there is no evidence indicating the best dressing. Although there is no evidence available for the ideal replacement frequency, the risk to develop skin irritation is reduced in longer dressing replacements intervals.
Appendix
Available only for authorised users
Literature
4.
go back to reference Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R (2007) A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45:1296–1304. https://doi.org/10.1086/522533 CrossRefPubMed Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, Garrè ML, Moroni C, Conte M, Losurdo G, Scuderi F, Bandettini R, Tomà P, Viscoli C, Haupt R (2007) A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 45:1296–1304. https://​doi.​org/​10.​1086/​522533 CrossRefPubMed
6.
go back to reference Hoffmann KK, Weber DJ, Samsa GP, Rutala WA (1992) Transparent polyurethane film as an intravenous catheter dressing. JAMA 267:2072–2076CrossRefPubMed Hoffmann KK, Weber DJ, Samsa GP, Rutala WA (1992) Transparent polyurethane film as an intravenous catheter dressing. JAMA 267:2072–2076CrossRefPubMed
7.
go back to reference Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R (1999) A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 27(6):488–496CrossRefPubMed Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R (1999) A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. Am J Infect Control 27(6):488–496CrossRefPubMed
11.
go back to reference Margatho AS, Ciol MA, Hoffman JM, Dos Reis PED, Furuya RK, Lima DAFS, Basile-Filho A, Silveira RCCP (2018) Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: a pilot randomised controlled trial. Aust Crit Care S1036-7314:1–8. https://doi.org/10.1016/j.aucc.2018.11.001 CrossRef Margatho AS, Ciol MA, Hoffman JM, Dos Reis PED, Furuya RK, Lima DAFS, Basile-Filho A, Silveira RCCP (2018) Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: a pilot randomised controlled trial. Aust Crit Care S1036-7314:1–8. https://​doi.​org/​10.​1016/​j.​aucc.​2018.​11.​001 CrossRef
14.
go back to reference Rasero L, Degl’Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G (2000) Comparison of two different protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized multicenter study. Haematologica 85:275–279 http://www.haematologica.org/content/85/3/275.full.pdf+html. Accessed May 1st, 2019 Rasero L, Degl’Innocenti M, Mocali M, Alberani F, Boschi S, Giraudi A, Arnaud MT, Zucchinali R, Paris MG, Dallara R, Thaler S, Perobelli G, Parfazi S, De Lazzer T, Peron G (2000) Comparison of two different protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized multicenter study. Haematologica 85:275–279 http://​www.​haematologica.​org/​content/​85/​3/​275.​full.​pdf+html. Accessed May 1st, 2019
15.
go back to reference Benhamou E, Fessard E, Com-Nougué C, Beaussier PS, Nitenberg G, Tancrède C, Dodeman S, Hartmann O (2002) Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomized trial. Bone Marrow Transplant 29:653–658 https://www.nature.com/articles/1703511. Accessed May 1st, 2019CrossRefPubMed Benhamou E, Fessard E, Com-Nougué C, Beaussier PS, Nitenberg G, Tancrède C, Dodeman S, Hartmann O (2002) Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: results of a randomized trial. Bone Marrow Transplant 29:653–658 https://​www.​nature.​com/​articles/​1703511. Accessed May 1st, 2019CrossRefPubMed
16.
go back to reference Vokurka S, Bystricka E, Visokaiova M, Scudlova J (2009) Once-versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. Med Sci Monit 15:CR107–CR110PubMed Vokurka S, Bystricka E, Visokaiova M, Scudlova J (2009) Once-versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. Med Sci Monit 15:CR107–CR110PubMed
21.
go back to reference Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJ (2016) A randomized trial on chlorhexedine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 27:1916–1922. https://doi.org/10.1093/annonc/mdw275 CrossRefPubMed Biehl LM, Huth A, Panse J, Krämer C, Hentrich M, Engelhardt M, Schäfer-Eckart K, Kofla G, Kiehl M, Wendtner CM, Karthaus M, Ullmann AJ, Hellmich M, Christ H, Vehreschild MJ (2016) A randomized trial on chlorhexedine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol 27:1916–1922. https://​doi.​org/​10.​1093/​annonc/​mdw275 CrossRefPubMed
22.
go back to reference Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P (1991) A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nurs Forum 18:1349–1356PubMed Shivnan JC, McGuire D, Freedman S, Sharkazy E, Bosserman G, Larson E, Grouleff P (1991) A comparison of transparent adherent and dry sterile gauze dressings for long-term central catheters in patients undergoing bone marrow transplant. Oncol Nurs Forum 18:1349–1356PubMed
23.
go back to reference Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF (1996) Comparison of central venous catheter dressing in bone marrow transplant recipients. Oncol Nurs Forum 23:829–836PubMed Brandt B, DePalma J, Irwin M, Shogan J, Lucke JF (1996) Comparison of central venous catheter dressing in bone marrow transplant recipients. Oncol Nurs Forum 23:829–836PubMed
24.
go back to reference Olson K, Rennie RP, Hanson J, Ryan M, Gilpin J, Falsetti M, Heffner T, Gaudet S (2004) Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs 27:37–44CrossRefPubMed Olson K, Rennie RP, Hanson J, Ryan M, Gilpin J, Falsetti M, Heffner T, Gaudet S (2004) Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites. J Infus Nurs 27:37–44CrossRefPubMed
25.
Metadata
Title
Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis
Authors
Renata Cristina de Campos Pereira Silveira
Paula Elaine Diniz dos Reis
Elaine Barros Ferreira
Fernanda Titareli Merizio Martins Braga
Cristina Maria Galvão
Alexander Michael Clark
Publication date
01-02-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05065-9

Other articles of this Issue 2/2020

Supportive Care in Cancer 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine